Health & Personal Care
HIGH
FDA DRUG
Graviti Pharmaceuticals Recalls Bupropion Hydrochloride Tablets Due to Hazard
Graviti Pharmaceuticals recalled 46,512 bottles of Bupropion Hydrochloride Extended-Release Tablets on September 15, 2025. The recall stems from failed tablet specifications that could affect safety and efficacy. The product was distributed to pharmacies nationwide.
BUPROPION HYDROCHLORIDE
Failed Tablet/Capsule